Escherichia coliIn Escherichia coli, yiaK is the first gene in a nine-gene operon (1), yiaKLMNOPQRS (yiaK-S), that is believed to be required for the utilization of rare sugars for growth. Mutational deactivation of the regulator of this operon, yiaJ, located just prior to yiaK but in the opposite orientation, leads to the constitutive expression of all the proteins of the operon, which enables bacteria carrying this mutation to utilize the rare pentose L-lyxose (2). However, not all of the genes of the operon are needed for the metabolism of this sugar. It is believed that L-lyxose is first converted to L-xylulose. Then the YiaP, YiaR, and YiaS proteins, encoded in the second half of the operon, can convert L-xylulose to D-xylulose 5-phosphate, which can in turn enter the pentose phosphate pathway (3). Therefore, it is likely that L-xylulose is only an intermediate from the action of the YiaK-S proteins on the genuine substrate(s) of this operon, which is currently still unknown (4).The YiaK protein catalyzes the reduction of 2,3-diketo-Lgulonate (DKG) 1 in the presence of NADH, and the product of the reduction is believed to be 3-keto-L-gulonate (see Fig. 1A) (5, 6). DKG can be obtained from the hydrolysis of L-dehydroascorbate. Another operon in E. coli, yif-sga (now known as ula), is involved in the fermentation of L-ascorbate (5). The yiaK-S operon may be involved in the utilization of L-dehydroascorbate.YiaK belongs to a large family of putative oxidoreductases that have members from bacteria and archaea, as well as eukaryotes (see Fig. 1B). There are four additional homologs of YiaK in E. coli, two of which are shown in Fig. 1B. Many members of this family are annotated as type 2 malate/lactate dehydrogenase in the various sequence data bases, although there is only minimal biochemical evidence supporting this classification. Moreover, members of this family do not share any recognizable sequence homology to other NAD(P)-binding proteins. For example, the YiaK proteins do not contain the GXGXX(G/A) dinucleotide binding signature motif (7). As a matter of fact, these proteins do not share any significant sequence homology with any other proteins that have known three-dimensional structures.To help understand the biochemical functions of these enzymes, we have determined the crystal structures of the free enzyme of YiaK and its complex with NAD-tartrate at up to a 2.0-Å resolution. The structures reveal a new polypeptide backbone fold for the enzyme as well as a novel mode of binding the NAD cofactor, establishing the YiaK enzymes as a new class of NAD(P)-dependent oxidoreductases. In addition, our crystallographic analysis unexpectedly showed the binding of tartrate in the active site. Enzyme kinetics studies confirm that tartrate and the related D-malate are competitive inhibitors of YiaK. Large conformational differences are observed between the free enzyme and the NAD-tartrate complex. In contrast to most other enzymes in which substrate binding produces a more closed conformation, the binding of NAD-ta...